Global Biosimilars Industry 2015 Trends & Opportunities Discussed in New Research Report
DALLAS, January 25, 2015 /PRNewswire/ --
MarketReportsOnline.com adds Global Biosimilar Market Trends & Opportunities: 2015 Edition research report of 80 pages on the biosimilars industry to the pharmaceuticals intelligence collection of its research store.
The report titled "The Global Biosimilar Market: Trends & Opportunities (2014-2018)" provides an in-depth analysis of the growing Biosimilar Market with detailed analysis of market sizing and growth, market share and economic impact of the industry. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall Biosimilars industry has also been forecasted for the period 2014-18, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Sandoz, Teva, Hospira and Dr. Reddy's Lab are profiled.
Rising budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for cost-effective alternatives, increasing aging population, conductive government initiatives and rising incidences of various diseases are significant factors that are responsible for the growth of global biosimilar market (2013 to 2018). On the other hand stringent regulatory environment in some countries, high manufacturing complexities, costs, and presence of low priced generic drugs and high-entry barriers are considered to hinder the market growth. Emerging pharmaceutical market and less stringent government regulatory frameworks in few countries can provides some of the major opportunities for biosimilars market. In addition, increased collaboration between manufacturing companies and outsourcing of biosimilar products are key trends for biosimilars market.
Purchase a copy of this research report at http://www.marketreportsonline.com/contacts/purchase.php?name=395635 .
The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. Globally there are 280 biosimilars in pipeline and their clinical trials are increasing at a rate of 20% annually.
Product Coverage:
- Recombinant Glycosylated Biosimilars (EPO,mAb,Follitropin)
- Humira, Enbrel, Remicade, Herceptin
- Recombinant Non-Glycosylated Biosimilars (Insulin,G-csf,Interferons,hGh)
This report analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report.
Major points from Table of Contents are listed below:
1. Executive Summary
2. Global Biosimilar Market
3. Global Biosimilar Market: Sizing and Growth
4. Biosimilar Market Analysis: By Geography
5. Biosimilar Market: Product Analysis
6. Market Dynamics of Biosimilar Market
7. Competitive Landscape: Global Biosimilar Market
8. Company profiles Global Biosimilar Market
List of Tables and Figures
Other Related Reports on Pharmaceuticals Market:
US Pharmacy Benefit Management (PBM) Industry Report: 2014 Edition at http://www.marketreportsonline.com/395328.html .
Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19) at http://www.marketreportsonline.com/394315.html.
About Us:
MarketReportsOnline.com comprises of an online library of 500,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
SOURCE Market Reports Online
Share this article